Disulfiram

Disulfiram Service Level Agreement 2020/2023 v2 - January 2022

Disulfiram Service Guidance v1 (August 2021)

ADRS Guideline for Use of Alcohol Protective Medication v1 

 

IF YOU ARE A BRANCH OF BOOTS, LLOYDS, ROWLANDS, WELL, WILLIS, MORRISONS, GILBRIDE’S & INVERCOAST YOU ARE NOT REQUIRED TO SIGN THE SLA AS THESE COMPANIES OPERATE A SINGLE SIGN UP PROCESS WHICH IS MANAGED VIA A CENTRAL POINT.

 

For those pharmacies registered to provide the supervised disulfiram service:

Historically within GG&C, pharmacies have been paid per supervision of disulfiram, which made claiming complicated and cumbersome.  On 1st July 2020, the Pharmacy Contractors Committee agreed to a £15 single monthly payment for disulfiram patients.  A patient needs to attend once or more for disulfiram supervision in a calendar month or have instalment dispensing specified on their prescription without supervision.  Communicating any concerns, for example a missed dose/collection, promptly (within 24 hours) remains the most important part of the service.  An interim claim form was employed (July to October 2020) while a NEO module was under development.  The NEO module will now go live on 1st November 2020. 

 

From 1st November, the new NEO alcohol module should be used for:

  • Recording/reporting a missed dose of disulfiram (within 24 hours), the system will send an automated email to the team for you.  No further doses should be supplied/supervised until the team has advised to do so.
  • Monthly paper free disulfiram claims (first claim in December 2020 for service provided in November 2020).

 

Breathalysing although usually a standard part of the service, as previously communicated due to COVID-19 infection risk, breathalysing should not be part of the assessment until further notice. 

 

Please email ADRS.PharmacyTeam@ggc.scot.nhs.uk with any queries.

 

 

Responsible Person: Jennifer Torrens
Last Updated: 05/06/2023